Source: Annual Congress 2006 - Landmark developments in lung function testing: 2006



Rating:

Share or cite this content

Citations should be made in the following way:
M. P. Swanney, L. E. Beckert, C. M. Frampton, R. L. Jensen, R. O. Crapo (Christchurch, New Zealand; Salt Lake City, United States Of America). IsovolumeFEF_25-75%6 and FEV₁ for identifying bronchodilator response. Eur Respir J 2006; 28: Suppl. 50, 977

Member's Comments

No comment yet.

Related content which might interest you: How often FEV1 underestimates bronchodilator response? Source: Eur Respir J 2003; 22: Suppl. 45, 100s Year: 2003 Comparison of bronchodilatator response of FEV1 and airway resistance Source: Annual Congress 2003 - Assessing airway function: practicalities and clinical applications Year: 2003 FEF25-75% should not yet be used to define a bronchodilator response in individuals Source: Annual Congress 2005 - Spirometry - now and in the future Year: 2005 Immediate bronchodilator response in FEV1 as a diagnostic criterion for adult asthma Source: Eur Respir J, 53 (2) 1800904; 10.1183/13993003.00904-2018 Year: 2019 Immediate bronchodilation response in FEV1 as a diagnostic criterion of adult asthma Source: International Congress 2018 – Clinical markers of asthma Year: 2018 Influence of basal FEV1 on the response to bronchodilator agents in COPD Source: Eur Respir J 2001; 18: Suppl. 33, 426s Year: 2001 Normal lung function and absence of bronchodilator response in children with stable, controlled asthma using inhaled corticosteroids Source: Annual Congress 2006 - New features of paediatric asthma Year: 2006 sGaw as an alternative for FEV1 in the measurement of airway responsiveness to methacholine in patients experiencing chronic cough Source: Annual Congress 2011 - Lung function today and tomorrow I Year: 2011 Bronchyal hyperreactivity estimated by bronchodilatator test and FEF25-75/FVC ratio Source: Eur Respir J 2007; 30: Suppl. 51, 744s Year: 2007 Maximally attained level of FEV1 and FEV1 decline determine airway hyperresponsiveness in adults Source: Eur Respir J 2003; 22: Suppl. 45, 17s Year: 2003 Closing volume predicts the FEV1 response to bronchodilators in patients with COPD Source: Virtual Congress 2020 – Advances in lung function testing Year: 2020 Comparison of FEV1 and PEF values in cough variant asthma during methacholine challenge test Source: Annual Congress 2010 - Cough, airway hyperresponsiveness and asthma control Year: 2010 Evaluation of the response of airway obstruction to short-acting inhaled broncodilators with using FIV1 and FEV1 in COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 290s Year: 2005 Differentiation of bronchodilator effects of indacaterol and formoterol by FEV1 and inspiratory capacity (IC) in patients with COPD Source: Annual Congress 2007 - New drugs for COPD Year: 2007 The role of forced partial expiratory flows to test the bronchodilator response in COPD Source: Annual Congress 2012 - Pathophysiological mechanisms in disease: new insights Year: 2012 A comparison of the response to inhaled histamine measured with FEV1 and sGaw in healthy subjects Source: Annual Congress 2003 - Assessing airway function: practicalities and clinical applications Year: 2003 Spirometric changes in bronchodilation tests as predictors of asthma diagnosis and treatment response in patients with FEV1 =80% predicted Source: Virtual Congress 2021 – Advances in asthma treatment Year: 2021 FEV6 and FEV1/FEV6 as an alternative for FVC and FEV1/FVC in monitoring response to prednisolone treatment Source: Annual Congress 2010 - Quality measurement and improvement in lung function Year: 2010 The influence of FVC manoeuvres on consecutive FEV1 values during methacholine challenge Source: Eur Respir J 2004; 24: Suppl. 48, 587s Year: 2004 Patterns of bronchodilator reversibility of FEV1 in asthma and COPD patients Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD Year: 2012